159 related articles for article (PubMed ID: 29957028)
1. Cellular target engagement: a new paradigm in drug discovery.
Babic I; Kesari S; Nurmemmedov E
Future Med Chem; 2018 Jul; 10(14):1641-1644. PubMed ID: 29957028
[No Abstract] [Full Text] [Related]
2. Biologically active metabolites in drug discovery.
Sun S; Wesolowski SS
Bioorg Med Chem Lett; 2021 Sep; 48():128255. PubMed ID: 34245850
[TBL] [Abstract][Full Text] [Related]
3. The current limits in virtual screening and property prediction.
Hutter MC
Future Med Chem; 2018 Jul; 10(13):1623-1635. PubMed ID: 29953247
[TBL] [Abstract][Full Text] [Related]
4. Confident application of a global human liver microsomal activity QSAR.
Stålring J; Sohlenius-Sternbeck AK; Terelius Y; Parkes K
Future Med Chem; 2018 Jul; 10(13):1575-1588. PubMed ID: 29953260
[TBL] [Abstract][Full Text] [Related]
5. Deep learning approaches in predicting ADMET properties.
Cáceres EL; Tudor M; Cheng AC
Future Med Chem; 2020 Nov; 12(22):1995-1999. PubMed ID: 33124448
[No Abstract] [Full Text] [Related]
6. Phenotypic approaches to small-molecule discovery in chemical biology.
Wagner BK; Dey M
Cell Chem Biol; 2021 Mar; 28(3):245. PubMed ID: 33740431
[No Abstract] [Full Text] [Related]
7. Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery.
Pérot S; Sperandio O; Miteva MA; Camproux AC; Villoutreix BO
Drug Discov Today; 2010 Aug; 15(15-16):656-67. PubMed ID: 20685398
[TBL] [Abstract][Full Text] [Related]
8. Targeting RNA with Small Molecules To Capture Opportunities at the Intersection of Chemistry, Biology, and Medicine.
Disney MD
J Am Chem Soc; 2019 May; 141(17):6776-6790. PubMed ID: 30896935
[TBL] [Abstract][Full Text] [Related]
9. Early repositioning through compound set enrichment analysis: a knowledge-recycling strategy.
Temesi G; Bolgár B; Arany A; Szalai C; Antal P; Mátyus P
Future Med Chem; 2014 Apr; 6(5):563-75. PubMed ID: 24649958
[TBL] [Abstract][Full Text] [Related]
10. Extending the small-molecule similarity principle to all levels of biology with the Chemical Checker.
Duran-Frigola M; Pauls E; Guitart-Pla O; Bertoni M; Alcalde V; Amat D; Juan-Blanco T; Aloy P
Nat Biotechnol; 2020 Sep; 38(9):1087-1096. PubMed ID: 32440005
[TBL] [Abstract][Full Text] [Related]
11. Current Advances in Computational Approaches for Drug Discovery- Part II.
Gupta AK
Curr Top Med Chem; 2018; 18(27):2267. PubMed ID: 30767732
[No Abstract] [Full Text] [Related]
12. Small molecules and their role in effective preclinical target validation.
Clegg MA; Tomkinson NC; Prinjha RK; Humphreys PG
Future Med Chem; 2017 Sep; 9(14):1579-1582. PubMed ID: 28828889
[No Abstract] [Full Text] [Related]
13. Efficient hit and lead compound evaluation strategy based on off-rate screening by surface plasmon resonance.
Liu L
J Med Chem; 2014 Apr; 57(7):2843-4. PubMed ID: 24654838
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in identifying protein targets in drug discovery.
Ha J; Park H; Park J; Park SB
Cell Chem Biol; 2021 Mar; 28(3):394-423. PubMed ID: 33357463
[TBL] [Abstract][Full Text] [Related]
15. Integrating the Impact of Lipophilicity on Potency and Pharmacokinetic Parameters Enables the Use of Diverse Chemical Space during Small Molecule Drug Optimization.
Miller RR; Madeira M; Wood HB; Geissler WM; Raab CE; Martin IJ
J Med Chem; 2020 Nov; 63(21):12156-12170. PubMed ID: 32633947
[TBL] [Abstract][Full Text] [Related]
16. Expanding the medicinally relevant chemical space with compound libraries.
López-Vallejo F; Giulianotti MA; Houghten RA; Medina-Franco JL
Drug Discov Today; 2012 Jul; 17(13-14):718-26. PubMed ID: 22515962
[TBL] [Abstract][Full Text] [Related]
17. Structure-based druggability assessment--identifying suitable targets for small molecule therapeutics.
Fauman EB; Rai BK; Huang ES
Curr Opin Chem Biol; 2011 Aug; 15(4):463-8. PubMed ID: 21704549
[TBL] [Abstract][Full Text] [Related]
18. Learning from PAINful lessons.
Erlanson DA
J Med Chem; 2015 Mar; 58(5):2088-90. PubMed ID: 25710486
[TBL] [Abstract][Full Text] [Related]
19. Methods for docking small molecules to macromolecules: a user's perspective. 2. Applications.
Campagna-Slater V; Therrien E; Weill N; Moitessier N
Curr Pharm Des; 2014; 20(20):3360-72. PubMed ID: 23947644
[TBL] [Abstract][Full Text] [Related]
20. Chemoproteomic-enabled phenotypic screening.
Conway LP; Li W; Parker CG
Cell Chem Biol; 2021 Mar; 28(3):371-393. PubMed ID: 33577749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
